• Greater Twin Cities: 715.294.4371

  • Search

Purchase Tazarotene (Tazorac) gel online


How and where to order Tazorac (Tazarotene) 0.05% and 0.1% 20 g gel online:

Shop: MEDS FOR SALE - 5% discount coupon 5OFF
Prices: from $25.99 per tube
Forms: Tazarotene (Tazorac) 0.05% and 0.1% 20 g topical gel
Quantity: 1-5 tubes
Type: Tazarotene brand, Tazorac generic
Payment: Visa, Mastercard, AmEx, Bitcoin
Delivery: Standard airmail and trackable courier services
Shipping: Worldwide, including USA, UK, Europe, Canada, Australia

Tazarotene (trade names include Tazorac, Fabior, Tazotop, Tazret, Zorac) is a dermatological medication from antipsoriatics for topical use pharmacological group. This medicine is used for the treatment of psoriasis, acne, photodamage (sun damaged skin), including associated with skin irritation and erythema; to reduce skin wrinkling and liver spots. It works as retinoid prodrug by affecting the growth of skin cells.


Tazorac (Tazarotene) 0.1% 20 g gel


Related medications:

  • Adapalene (Differin)
  • Azelaic Acid (Azelex)
  • Benzoyl Peroxide (Benzac)
  • Butenafine (Mentax)
  • Calcipotriol (Daivonex)
  • Calcipotriol, Betamethasone (Daivobet)
  • Calcitriol (Rocaltrol, Calcijex)
  • Clindamycin, Tretinoin (Ziana)
  • Cyclosporine (Neoral)
  • Eflornithine (Vaniqa)
  • Fluorouracil (Efudex)
  • Fumaric Acid (Lichenic Acid)
  • Imiquimod (Aldara)
  • Mometasone (Elocon)
  • Mupirocin (Bactroban)
  • Permethrin (Acticin)
  • Tacalcitol (Bonalfa)
  • Tretinoin (Renova)
  • Triamcinolone (Aristocort)


    Pharmacological and medical categories:

  • Anti acne medications
  • Anti psoriasis drugs
  • Photodamaged skin treatment
  • Skin care products
  • Topical retinoids
  • Vitamin A derivatives


    ATC codes:

  • D - Dermatologicals
  • D05 - Antipsoriatics
  • D05A - Antipsoriatics for topical use
  • D05AX - Other antipsoriatics for topical use
  • D05AX05 - Tazarotene


    ICD-10 codes:

  • Psoriasis - L40
  • Other erythematous conditions - L53
  • Other acute skin changes due to ultraviolet radiation - L56
  • Acne - L70
  • Other disorders of pigmentation - L81
  • Other melanin hyperpigmentation - L81.4
  • Other disorders of skin and subcutaneous tissue, not elsewhere classified - L98


    Indications and usage:

  • Tazorac (Tazarotene) cream and gel 0.05% and 0.1% is a retinoid indicated for the topical treatment of plaque psoriasis.
  • Tazarotene gel and cream 0.1% is indicated for the topical treatment of acne vulgaris.


    Dosage and administration:

  • Apply a thin layer of Tazorac (Tazarotene) cream or gel only to the affected area once daily in the evening.
  • Not for ophthalmic, oral, or intravaginal use.
  • If contact with eyes occurs, rinse thoroughly with water.


    Overdosage:

    Excessive topical use of Tazorac gel may lead to marked redness, peeling, or discomfort. Tazarotene gel 0.05% and 0.1% are not for oral use. Oral ingestion of the drug may lead to the same adverse effects as those associated with excessive oral intake of Vitamin A (hypervitaminosis A) or other retinoids. If oral ingestion occurs, the patient should be monitored, and appropriate supportive measures should be administered as necessary.


    Dosage forms and strengths:

    Tazarotene cream, gel 0.05% and 0.1%.


    Contraindications:

  • Pregnancy
  • Hypersensitivity


    Warnings and precautions:

  • Embryofetal Toxicity: Tazorac cream and gel contains tazarotene, which is a teratogenic substance. Tazarotene is contraindicated in pregnancy. Females of child-bearing potential should have a negative pregnancy test within 2 weeks prior to initiating treatment and use an effective method of contraception during treatment.
  • Local Irritation: Some individuals may experience excessive pruritus, burning, skin redness or peeling. If these effects occur, discontinue until the integrity of the skin has been restored, or reduce dosing interval, or in the case of psoriasis, may switch to the lower concentration. Tazorac gel and cream should not be used on eczematous skin, as it may cause severe irritation.
  • Photosensitivity and Risk for Sunburn: Avoid exposure to sunlight, sunlamps, and weather extremes. Wear sunscreen daily. Tazarotene gel or cream should be administered with caution if the patient is also taking drugs known to be photosensitizers.


    Adverse reactions, side effects:

  • Plaque psoriasis: Most common adverse reactions occurring in 10 to 23% of patients are pruritus, erythema, and burning.
  • Acne Vulgaris: Most common adverse reactions occurring in 10 to 30% of patients are desquamation, dry skin, erythema, and burning sensation.


    Drug interactions:

    Concomitant dermatologic medications and cosmetics that have a strong drying effect should be avoided. It is also advisable to "rest" a patient's skin until the effects of such preparations subside before use of Tazorac gel is begun. In a study of 27 healthy female subjects between the ages of 20 - 55 years receiving a combination oral contraceptive tablet containing 1 mg norethindrone and 35 mcg ethinyl estradiol, concomitant use of tazarotene did not affect the pharmacokinetics of norethindrone and ethinyl estradiol over a complete cycle. The impact of tazarotene on the pharmacokinetics of progestin only oral contraceptives (i.e., minipills) has not been evaluated.


    Pregnancy categories:

  • D - Australia
  • X - United States (Should not be used during pregnancy)


    Salts and other forms:

  • Tazarotene Base


    Synonyms, international and chemical names:

  • Tazaroten
  • Tazarotena
  • Tazarotenum


    Brands, generics, trade names:

  • Avage - Sanofi-Aventis, Allergan, IDS Group
  • Fabior - Mayne Pharma
  • Tazorac - Allergan, Medibrands, Pierre Fabre
  • Tazotop - Sun Pharmaceutical Industries
  • Tazret - Glenmark Pharmaceuticals
  • Zorac - Allergan, Pierre Fabre


    References:

  • Tazarotene main article on Wikipedia: https://en.wikipedia.org/wiki/Tazarotene
  • Tazarotene compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Tazarotene
  • Tazarotene medicine on DrugBank: https://www.drugbank.ca/drugs/DB00799
  • Topical Tazarotene FAQ on MedlinePlus (revised 06/15/2019): https://medlineplus.gov/druginfo/meds/a616052.html
  • Tazorac (Tazarotene) cream drug label on DailyMed (revised July 31, 2017): https://dailymed.nlm.nih.gov/dailymed/drugInfo...
  • Tazarotene containing drugs on Drugs-About.com: https://drugs-about.com/ing/tazarotene.html
  • Tazarotene for sale on Pharma Doctor (revised May 2022): https://pharma-doctor.com/tazarotene.html
  • Tazorac (Tazarotene) gel 0.05% and 0.1% official prescribing information and medication guide from the U.S. FDA (revised 02/2011): https://www.accessdata.fda.gov/drugsatfda_docs/label...
  • Tazorac (Tazarotene) cream 0.05% and 0.1% official prescribing information and medication guide from the U.S. FDA (revised 12/2013): https://www.accessdata.fda.gov/drugsatfda_docs/label...
  • Tazorac (Tazarotene) cream 0.05% and 0.1% prescribing and patient information from Allergan pharmaceutical company (revised 07/2017): https://media.allergan.com/actavis/actavis/media/allergan...
  • Zorac (Tazarotene) 0.05% gel and 0.1% gel topical patient information leaflet on Medicines.org.uk (revised July 2018): https://www.medicines.org.uk/emc/files/pil.6762.pdf
  • Tazret Gel (Tazarotene) from Glenmark Pharmaceuticals Ltd on Practo website: https://www.practo.com/medicine-info/tazret-gel-51976

    Revised: May 2022
  • Preclinical Testing Solutions
    Throughout the
    Product Innovation Cycle.